SUA reduction of the levels of endothelial nitric oxide (NO), which is a mediator of insulin action and increases blood flow to skeletal muscle, induces endothelial dysfunction and enhances insulin resistance in the liver, muscle, and adipose tissues [19]. This evidence concerns the gene INS and endothelial dysfunction.